The comparison of TDP-43-WT versus TDP-43-”ΔNES” shows a suppression of the known amyloidogenic core at residues 244–255 (Figure 4), exposed in ALS patients (Saini and Chauhan, 2011; Shodai et al., 2012). Here, TARDBP is linked to amyotrophic lateral sclerosis.